Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

IL-15 Protein (AA 49-162)

Recombinant IL-15 protein expressed in Escherichia coli (E. coli).
Catalog No. ABIN6386427

Quick Overview for IL-15 Protein (AA 49-162) (ABIN6386427)

Target

See all IL-15 (IL15) Proteins
IL-15 (IL15) (Interleukin 15 (IL15))

Protein Type

Recombinant

Biological Activity

Active

Origin

  • 21
  • 8
  • 4
  • 4
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
Human

Source

  • 34
  • 10
  • 9
  • 3
  • 1
Escherichia coli (E. coli)

Purity

>95 % as determined by SDS-PAGE.
  • Protein Characteristics

    AA 49-162

    Sequence

    AA 49-162

    Endotoxin Level

    Less than 0.1 EU per μg by the LAL method.
  • Want other Options for this Protein ?

    !
    Discover Our Predefined Custom Proteins and Custom Protein Services!

    Your project requires further customization? Contact us and discover our custom protein solutions

  • Restrictions

    For Research Use only
  • Format

    Lyophilized

    Buffer

    PBS, pH 7.4

    Handling Advice

    Please avoid repeated freeze-thaw cycles.

    Storage

    -20 °C
  • Target

    IL-15 (IL15) (Interleukin 15 (IL15))

    Alternative Name

    IL-15

    Background

    Interleukin 15 is also known as IL15, IL-15, and is a cytokine with structural similarity to IL-2. Like IL-2, IL-15 binds to and signals through the IL-2/IL-15 beta chain (CD122) and the common gamma chain (gamma-C, CD132). IL-15 is secreted by mononuclear phagocytes (and some other cells) following infection by virus(es). This cytokine induces cell proliferation of natural killer cells, cells of the innate immune system whose principal role is to kill virally infected cells. Interleukin 15 (IL-15) regulates T and natural killer (NK) cell activation and proliferation. Survival signals that maintain memory T cells in the absence of antigen are provided by IL-15. This cytokine is also implicated in NK cell development. In rodent lymphocytes, IL-15 prevents apoptosis by inducing an apoptosis inhibitor, BCL2L1/BCL-x(L). IL-15 has been shown to enhance the anti-tumor immunity of CD8+ T cells in pre-clinical models. A phase I clinical trial to evaluate the safety, dosing, and anti-tumor efficacy of IL-15 in patients with metastatic melanoma and renal cell carcinoma (kidney cancer) has begun to enroll patients at the National Institutes of Health.

    Molecular Weight

    12.8 kDa

    Pathways

    JAK-STAT Signaling, Glycosaminoglycan Metabolic Process
You are here:
Chat with us!